Governor Rick Perry and Brian Wallach, CEO of Americans for Ibogaine, return to discuss their unprecedented success in securing state funding for ibogaine research and treatment development.

The conversation covers their 15-month campaign that culminated in Texas committing $100 million to develop ibogaine as an FDA-approved medication for addiction and trauma treatment.

Perry shares his personal transformation from skeptic to advocate, driven by his relationship with Navy SEAL Marcus Luttrell and his own ibogaine treatment experience that reversed brain atrophy.

The discussion explores the spiritual and scientific dimensions of ibogaine, referencing A Christian's Guide to Psychedelics and The Sacred Mushroom and the Cross in the context of religious acceptance of plant medicines.

Texas Commits $100 Million to Ibogaine Development

Texas approved full $100 million funding for the Texas Ibogaine Initiative, doubling the original $50 million request and eliminating need for private partnership

The campaign secured votes from 181 out of 188 Texas legislators after a five-and-a-half-month intensive lobbying effort

Lieutenant Governor Dan Patrick's approval came just 36 hours before the budget deadline on May 16th, following personal advocacy from Marcus and Morgan Luttrell

Ibogaine's Unprecedented Addiction Treatment Success

Ibogaine achieves 85% success rate for opioid addiction treatment in 48-72 hours with one dose, rising to 98% with two treatments

Stanford functional MRIs show ibogaine restores addicted brains to normal appearance in 72 hours, compared to 18 months through traditional abstinence programs

The compound interrupts physiological substance dependency for opioids, alcohol, methamphetamine, cocaine, tobacco, and compulsive behaviors like gambling

Ibogaine's neuroplasticity window lasts 90-120 days, far longer than ketamine's 48-72 hours or psilocybin's 14-28 days - Dr. Gul Dolan

Governor Perry's Personal Transformation and Brain Recovery

Perry underwent ibogaine treatment to address mild anxiety and insomnia from three severe concussions sustained in athletics and accidents

Brain scans showed 27% increase in prefrontal cortex activity one week post-treatment, with complete reversal of age-related atrophy at six months

"Your brain looks like a 40-year-old" - Dr. Charlie Gordon, neurosurgeon, after reviewing Perry's six-month post-treatment scans

Perry's evolution from drug war supporter to psychedelic advocate mirrors his earlier transformation on criminal justice reform in the 2000s

Multi-State Movement Gains Unprecedented Momentum

Mississippi passed legislation 111-1 in the House and 51-1 in the Senate, committing $5 million from opioid settlement funds

West Virginia passed their ibogaine bill unanimously in both chambers (96-0 in House, unanimous in Senate)

Tennessee Senate Finance Committee voted 11-0 to advance their bill, with Oklahoma House already passing theirs

Kentucky Senate passed their bill 35-2, now pending in the House where the movement originally began

Religious and Spiritual Dimensions of Plant Medicine

A Christian's Guide to Psychedelics by Wendy Rees addresses conservative Christian skepticism, written by a pastor's daughter who survived sexual abuse

Biblical scholars propose Moses's burning bush experience involved DMT-rich acacia trees, suggesting divine encounters through plant compounds

The Sacred Mushroom and the Cross by John Marco Allegro details psychedelic use in ancient Christianity based on Dead Sea Scrolls analysis

"Ibogaine confirms without question the reality of our individual human divinity" - Wallach on the compound's spiritual revelations

Federal Barriers and Right-to-Try Complications

DEA interprets federal Right to Try legislation as excluding Schedule I substances, despite author Kirsten Sinema's clarification that language covers 'any medication'

Once phase one safety testing completes, Right to Try should allow access for life-threatening conditions, but DEA's interpretation blocks this pathway

Presidential action could reschedule ibogaine from Schedule I to II/III, apply HALT-Fentanyl Act provisions, and direct proper Right to Try interpretation

International Partnerships and Native American Involvement

Government of Gabon named Americans for Ibogaine as official partner for global iboga medicine advancement

Choctaw Nation will seek to join Texas trial as third largest Native American tribe, with Inter Tribal Council meeting planned for April 7th

Five Civilized Tribes (Choctaw, Chickasaw, Cherokee, Muskegee, Seminole) expected to pass solidarity resolution supporting ibogaine integration

In Gabon, iboga shrubs grow in identical pairs - one therapeutic, one poisonous - requiring 10 years to differentiate through fruit production